TOP > About Us > Message from the President

Message from the President

The Best Partner in Clinical Nutrition

We mourn the loss of those who have died due to the COVID-19 pandemic which has continued since last year, and extend our sympathies to those affected, their families, and those involved. We would also like to express our gratitude to healthcare professionals and those who are devoted to preventing the spread of infection every day.

This unprecedented pandemic has led to major changes in society, economy, and our lifestyle. In this changing environment, we will continue to contribute to healthcare by engaging with patients and healthcare professionals, not only in the stable supply of pharmaceuticals, but also in the reforms of new information delivery systems using Web and digital.

Our corporate philosophy and management vision

Business operations in the Otsuka Group are based on the corporate philosophy “Otsuka-people creating new products for better health worldwide.” Our aim is to contribute to healthier lives of people worldwide by providing innovative and creative products including pharmaceuticals and functional foods and beverages. Within the Otsuka Group, the management vision of Otsuka Pharmaceutical Factory (OPF) is to be “The Best Partner in Clinical Nutrition.” We pursue business activities in a manner that meets the trust invested in us by all of our stakeholders, including patients and their families as well as the healthcare professionals who treat them.

Quality first spirit inherited from the founding

Otsuka Pharmaceutical Factory is the original company ―founded in 1921 as Otsuka Seiyaku Kogyobu (Otsuka Pharmaceutical)―from which the Otsuka Group has grown. For more than 70 years we have been developing intravenous (IV) solutions and, as a leading IV solution company, have steered their development in Japan. “Quality is vital in a factory and so is packaging. We have to manufacture and market, putting ourselves in the consumer’s position.” These words from the founder Busaburo Otsuka demonstrate a priority focus on quality in manufacturing. Keeping his philosophy in mind, we pledge to consistently deliver safe, high-quality products to patients and healthcare professionals with a strong sense of mission.

Creation of products that contribute to healthcare, ranging from prevention to hospital medical care, rehabilitation, and home medical/nursing care

In research and development, we are developing medicines and medical devices that meet unmet medical needs in the fields of surgical aid and regenerative medicine products as well as in the field of clinical nutrition. We work on innovative product development that is not constrained by existing concepts but is based on the patient’s viewpoint. In the medical food* field, including oral rehydration solution OS-1, in order to meet the growing needs in medical and nursing care fields, we are actively promoting research and development.
At the same time, we focus on contract manufacturing and aim to grow by acquiring new products and establishing new technologies by building relationships of trust with business partners through proposing products that leverage the IV solution-related technologies cultivated in the IV business and providing high-quality, efficient production systems. Thus, with the development of new products and technologies, we will contribute to medical care by providing a product line-up covering prevention, hospital medical care, rehabilitation, and home medical/nursing care, as well as detailed information.

We deliver products that contribute to people’s health and nutrition management to the world

Otsuka’s IV solutions are widespread not only in Japan but around the world, mainly in Asia. As a leading Japanese IV solution company, we are deeply involved in the management of the Otsuka Group’s overseas IV solution companies. In the future, we intend to further promote the development of products that can contribute to clinical nutrition widely, such as nutrient IV solutions and enteral nutrition products, as well as basic solutions that boast a high share in Indonesia and Egypt. And we will continue to strive to deliver medicines, medical devices, and medical foods in other fields.

Toward the next 100 years To continue to be a valuable company

This is a milestone year for the Otsuka Group and Otsuka Pharmaceutical Factory, marking the 100th anniversary of its founding in September 1921 as Otsuka Seiyaku Kogyobu. We once again keep in mind various teachings of our predecessors, such as “Ryukan-godo” (by sweat we recognize the way) by Busaburo Otsuka, the founder of the Otsuka Group, “Jissho” (actualization) by Masahito Otsuka, the second-generation president, and “Sozosei” (creativity) by the third-generation president, Akihiko Otsuka, and inherit them. Also, we believe that this is the year in which we will start toward the next goal, while maintaining “Otsuka values” toward the next 100 years. We will develop and supply innovative products while continuing to strive to stably deliver safe and high-quality products as a leading company in IV solutions.
We are committed to working together as a united force to continue to be a valuable company through our business activities. Specifically, we contribute not only to the health of people around the world but also to the achievement of sustainable development goals (SDGs) recommended by the United Nations by further strengthening environmentally friendly business management. We look forward to your continued support in these endeavors.

*We refer to the food products that we have developed based on medical and nutritional grounds, and which play a role in healthcare, as “medical foods.”

Shinichi Ogasawara
President and Representative Director